WEITERE NEUE FORMEN VON INTERFERIERENDE RNS MOLEKÜLE

Patent europeic · EP2258847 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2258847
Numer da la dumonda
EP10012263
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Mantegnì en furma midada
Annunzià
05-08-2003
Publitgà
08-12-2010
Concedì
15-03-2017
Stritgà
05-08-2023
Motiv
Durada maximala cuntanschida
Classas IPC
C12N 15/113 (2010.01)
A61K 31/713 (2006.01)
//C07H 21/00 (2006.01)
//C12Q 1/68 (2006.01)
//A01K 67/027 (2006.01)
//C12N 5/10 (2006.01)
Prioritad
EP 02017601 05.08.2002
US 402541 P 12.08.2002
EP 03008383 10.04.2003
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 05-08-2023

    Durada maximala cuntanschida

    Published in Swissreg on 05.08.2023

  2. 01-09-2022

    Midada

    Published in Swissreg on 01.09.2022

  3. 23-09-2021

    Midada

    Published in Swissreg on 23.09.2021

  4. 23-09-2021

    Midada

    Published in Swissreg on 23.09.2021

  5. 23-09-2021

    Midada

    Published in Swissreg on 23.09.2021

  6. 23-09-2021

    Midada

    Published in Swissreg on 23.09.2021

  7. 03-06-2020

    Midada

    Published in Swissreg on 03.06.2020

  8. 15-03-2017

    Concedì

    Published in Swissreg on 15.03.2017

Partidas

Possessur

Silence Therapeutics GmbH

Robert-Rössle-Strasse 10, 13125 Berlin, DE

Inventur

Giese, Klaus

Robert-Rössle-Str. 10, 13125 Berlin, DE

Kaufmann, Jörg

13465 Berlin, DE

Klippel-Giese, Anke

13125 Berlin, DE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.